Journal of Bone and Mineral Research

Cover image for Vol. 29 Issue 11

Edited By: Juliet E Compston

Impact Factor: 6.589

ISI Journal Citation Reports © Ranking: 2013: 12/123 (Endocrinology & Metabolism)

Online ISSN: 1523-4681

Recently Published Issues

See all

eCompendia

virtual issue

Call for Images

callimage

Announcing

JBMR® Announces Workflow Changes and Author Guidelines Updates

In response to rising concerns over the reproducibility of biomedical research, the author guidelines and submission procedures for the Journal of Bone and Mineral Research’s (JBMR®) have recently been updated. These updates affect the submission workflow of author forms required for peer review and publication, as detailed below:


ARRIVE: Authors submitting preclinical research are now required to complete an adapted ARRIVE (Animals in Research: Reporting In Vivo Experiments) checklist at submission.


CONSORT: Authors of manuscripts reporting results of clinical trials are now required to upload the CONSORT checklist at submission.


Author Agreement: The conflict of interest (COI) and copyright transfer (CTA) portions of the current Author Agreement can now be completed electronically as a web form, eliminating the need for authors to print, scan and upload a PDF form upon submission.


• COI information will be collected during submission via an online questionnaire on ScholarOne.


• The CTA will be completed at manuscript acceptance: If a manuscript is accepted for publication, the corresponding author will receive an e-mail prompt to log in to Author Services. Author Services is a Wiley web application that provides production tracking, as well as other resources for authors. From this site, corresponding authors can complete the CTA on behalf of all authors on the paper.

New Content

Subscribe to RSS headline updates from: Journal of Bone and Mineral Research
Powered by FeedBurner

Media Pickups

As seen MDLinx

Longitudinal hr-pqct and image registration detects endocortical bone loss in kidney transplantation patients

Journal of Bone and Mineral Research, 09/12/2014 Clinical Article

Nishiyama KK, et al. – The authors conclude that cortical porosity (Ct.Po) increases throughout the cortex after kidney transplant and this increase is particularly marked at the endocortical surface. These methods may prove useful for all high–resolution peripheral quantitative computed tomography (HR–pQCT) longitudinal studies, particularly when changes are expected at the endocortical.

Click Here

Abstract Here

As seen MDLinx

Growth and aging of proximal femoral bone – a study with women spanning three generations

Journal of Bone and Mineral Research, 09/12/2014 Clinical Article

Wang Q, et al. – The development of geometric properties precedes areal bone mineral density (aBMD) in puberty, resulting in relatively constant hip strength after menarche. This asynchronous growth leads to adaption of bone strength to the imposed loads, avoiding fractures in a biologically efficient manner. Both deterioration of aBMD and inadequate compensatory change in bone geometry after menopause contribute to the increased fracture risk later in life.

Click Here

Abstract Here

As seen MDLinx

Higher glucocorticoid secretion in the physiological range is associated with lower bone strength at the proximal radius in healthy children: importance of protein intake adjustment

Journal of Bone and Mineral Research, 09/11/2014 Clinical Article

Shi L, et al. – Higher glucocorticoid (GC) levels, even only within the physiological range, appear to already exert negative influences on bone modeling and remodeling during growth. The physiological data also suggest a relevant role of cortisone as the direct source for intracrine generated cortisol by bone cells' 11beta –HSD1.

Click Here

Abstract Here

As seen MDLinx

A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density

Journal of Bone and Mineral Research, 09/11/2014 Clinical Article

Recker R, et al. – Treatment of postmenopausal women with an antibody targeted against sclerostin resulted in substantial increases in spine and hip bone mineral density (BMD). These results support further study of blosozumab as a potential anabolic therapy for osteoporosis.

Abstract Here

SEARCH

SEARCH BY CITATION